Israel Englander’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Israel Englander’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,000	Closed	-$541K	–	6695
2024 Q2	$541K	Buy	+20,000	New	+$394K	﹤0.01%	4537

Israel Englander's LBPH Position: Q4 2024 in Review

Israel Englander sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 55,644 shares — an estimated $1.85M sold.

Israel Englander first reported a position in LBPH in Q1 2021 and held it in 12 quarters. The position peaked at $11.5M in Q1 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Israel Englander reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Israel Englander sold 55,644 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.85M.
Israel Englander first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
Israel Englander's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $11.5M in Q1 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.